Free Trial
→ Why Elon put $51 million into this (From True Market Insiders) (Ad) Buy ABOS Stock  Free ABOS Stock Alerts

Acumen Pharmaceuticals (ABOS) SEC Filings & 10K Form

Acumen Pharmaceuticals logo
$1.23 +0.07 (+6.03%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$1.30 +0.06 (+5.28%)
As of 03/27/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Acumen Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
01/23/2025
8:19 PM		Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:14 PM		Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:16 PM		Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:18 PM		Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:06 PM		Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:17 PM		Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:31 PM		Acumen Pharmaceuticals (Subject)
Siemers Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:32 PM		Acumen Pharmaceuticals (Subject)
Meisner Derek M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:24 PM		Acumen Pharmaceuticals (Subject)
OConnell Daniel Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:25 PM		Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
6:57 PM		Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:00 PM		Acumen Pharmaceuticals (Issuer)
Doherty James J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:02 PM		Acumen Pharmaceuticals (Issuer)
Schacterle Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:09 PM		Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
6:48 PM		Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
6:53 PM		Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
6:55 PM		Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
5:16 PM		Acumen Pharmaceuticals (Subject)
Meisner Derek M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2025
4:54 PM		Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2025
4:59 PM		Acumen Pharmaceuticals (Subject)
Barton Russell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2025
5:04 PM		Acumen Pharmaceuticals (Subject)
Siemers Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
4:24 PM		Acumen Pharmaceuticals (Issuer)
Schacterle Amy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
4:27 PM		Acumen Pharmaceuticals (Issuer)
Schacterle Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:42 PM		Acumen Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:48 AM		Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
4:26 PM		Acumen Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:40 PM		Acumen Pharmaceuticals (Issuer)
Drapkin Kimberlee C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:41 PM		Acumen Pharmaceuticals (Issuer)
Fountain Nathan B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:46 PM		Acumen Pharmaceuticals (Issuer)
Porter Derrell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:49 PM		Acumen Pharmaceuticals (Issuer)
Stalfort John A III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:51 PM		Acumen Pharmaceuticals (Issuer)
Stoppel Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:36 PM		Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:47 PM		Acumen Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
6:35 AM		Acumen Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
11:15 PM		Acumen Pharmaceuticals (Filer)
Form EFFECT
04/22/2024
3:33 PM		Acumen Pharmaceuticals (Filer)
Form ARS
04/22/2024
3:30 PM		Acumen Pharmaceuticals (Filer)
Form DEF 14A
04/22/2024
3:31 PM		Acumen Pharmaceuticals (Filer)
Form DEFA14A
03/27/2024
3:34 PM		Acumen Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/27/2024
3:34 PM		Acumen Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ABOS) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners
A $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOW
Expert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...
Stansberry Research | Sponsored
Elon Warns: Exec Order 14024 Targets Dollar
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...
Priority Gold | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...
Brownstone Research | Sponsored